Therapeutics
SWBEC researches and develops high-value therapeutic compounds derived from algae and biological treatment systems. These naturally occurring compounds have potential applications in healthcare, biotechnology, and pharmaceutical development while supporting sustainable biomanufacturing approaches.
A major area of research focuses on phycocyanin, a naturally occurring blue pigment produced by cyanobacteria that has demonstrated antioxidant, anti-inflammatory, and bioactive properties. SWBEC also investigates meso-biliverdin, a biosimilar compound related to biliverdin-IXα, which has attracted interest for its therapeutic potential and biological activity.
These compounds can be produced through algae-based systems that simultaneously support wastewater treatment, nutrient recovery, and the generation of valuable bioproducts. By integrating environmental engineering with biotechnology, SWBEC explores innovative pathways for producing therapeutic compounds from renewable biological resources.
SWBEC continues to advance research that supports sustainable production methods for high-value therapeutic products while creating new opportunities for resource recovery, environmental protection, and biomanufacturing.
Related Research
Current research includes algae-derived therapeutic compounds, phycocyanin production, meso-biliverdin development, nutrient recovery systems, and biological treatment technologies that support the production of high-value bioproducts.
Therapeutic
SWBEC is exploring the production of bio-based compounds with applications in the cosmetics industry. One of the primary compounds under investigation is ectoine, a naturally occurring molecule known for its protective properties and potential use in skincare products.
Ectoine can be produced using biological processes that utilize greenhouse gases and renewable resources, creating opportunities for sustainable manufacturing. Current research focuses on developing efficient production methods while evaluating applications that may help protect skin from environmental stressors and support skin health.
By integrating biotechnology, environmental engineering, and biomanufacturing, SWBEC is advancing research that supports the development of sustainable cosmetic ingredients derived from biological systems. This work contributes to the growing demand for environmentally responsible products while creating new opportunities for resource recovery and value-added bioproducts.
Related Research
Current research includes ectoine production through biological processes, greenhouse gas utilization, sustainable biomanufacturing, and the development of bio-based compounds for cosmetic applications. Research also explores potential connections between cosmetic, pharmaceutical, and therapeutic uses of these compounds.
Pharmaceuticals
SWBEC is developing sustainable biomanufacturing approaches for the production of biologically derived compounds with potential pharmaceutical applications. A primary area of research focuses on ectoine, a naturally occurring molecule produced through biological processes that can utilize greenhouse gases and renewable feedstocks.
Current research is investigating methods to efficiently produce ectoine and evaluate its potential applications in human health. Researchers are exploring how biologically derived compounds may contribute to future pharmaceutical and biomedical innovations, including applications related to respiratory health, neurodegenerative conditions, and other therapeutic areas.
By combining biological engineering, environmental biotechnology, and resource recovery, SWBEC seeks to develop sustainable pathways for producing high-value pharmaceutical compounds while reducing environmental impacts and creating new opportunities for biotechnology-driven manufacturing.
Related Research
SWBEC research includes ectoine production, greenhouse gas utilization, biological manufacturing systems, microbial biotechnology, and the development of high-value compounds for potential pharmaceutical applications. Ongoing efforts also explore collaborations with medical and research partners to evaluate future therapeutic uses of these compounds.
Pharmaceuticals
SWBEC is exploring sustainable approaches to produce ectoine, a high-value biological compound generated from greenhouse gases and methane. Current research focuses on developing efficient biological production systems while investigating potential applications of ectoine in human health.
Researchers are evaluating ectoine for possible use in areas such as respiratory health, including cystic fibrosis, as well as neurodegenerative diseases. These efforts are being pursued through collaborations with medical researchers and industry partners to better understand the compound’s therapeutic potential.
By combining environmental biotechnology, biological engineering, and resource recovery, SWBEC seeks to transform waste-derived resources into valuable compounds that may contribute to future pharmaceutical and biomedical applications.
Related Research
- Ectoine production from greenhouse gases and methane
- Sustainable biomanufacturing processes
- Potential applications in cystic fibrosis research
- Potential applications in neurodegenerative disease research
- Biological resource recovery and high-value compound production